Eric Hsu
Vermogen: 3 $ op 31-05-2026
Vermogen: 3 $ op 31-05-2026
Eric C.
Hsu is Senior VP-Pre-Clinical Research & Development at InMed Pharmaceuticals, Inc. since 2018.
Formerly, Dr. Hsu was VP-Scientific Affairs, Research & Operations at enGene, Inc. from 2002 to 2018.
Education includes an undergraduate degree from McGill University and a doctorate from the University of Toronto conferred in 1999.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-12-2025 | 2 ( 0% ) | 3 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Hoofd Techniek/Wetenschap/O&O | 13-03-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Operationeel Directeur | 01-01-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau